v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Common Class A
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2024 $ (9,533) $ 3 $ 481,289 $ 6 $ (490,831)
Beginning balance (in Shares) at Dec. 31, 2024   33,883,894      
Stock-based compensation 1,149   1,149    
Common stock issued under equity award plans (in Shares)   492,815      
Issuance of common stock, net of cost 13,933 $ 1 13,932    
Issuance of common stock, net of cost (in Shares)   1,335,807      
Other comprehensive income (loss) (9)     (9)  
Net income (loss) 22,759       22,759
Ending balance at Mar. 31, 2025 28,299 $ 4 496,370 (3) (468,072)
Ending balance (in Shares) at Mar. 31, 2025   35,712,516      
Beginning balance at Dec. 31, 2024 (9,533) $ 3 481,289 6 (490,831)
Beginning balance (in Shares) at Dec. 31, 2024   33,883,894      
Other comprehensive income (loss) (12)        
Net income (loss) 15,272        
Ending balance at Jun. 30, 2025 53,832 $ 4 529,393 (6) (475,559)
Ending balance (in Shares) at Jun. 30, 2025   40,370,914      
Beginning balance at Mar. 31, 2025 28,299 $ 4 496,370 (3) (468,072)
Beginning balance (in Shares) at Mar. 31, 2025   35,712,516      
Stock-based compensation 1,141   1,141    
Common stock issued under equity award plans (in Shares)   88,123      
Exercise of stock options 54   54    
Exercise of stock options (in Shares)   44,056      
Issuance of common stock under ESPP 76   76    
Issuance of common stock under ESPP (in Shares)   15,097      
Issuance of common stock, net of cost 14,450   14,450    
Issuance of common stock, net of cost (in Shares)   1,720,422      
Exercise of warrants 17,302   17,302    
Exercise of warrants (in Shares)   2,790,700      
Other comprehensive income (loss) (3)     (3)  
Net income (loss) (7,487)       (7,487)
Ending balance at Jun. 30, 2025 53,832 $ 4 529,393 (6) (475,559)
Ending balance (in Shares) at Jun. 30, 2025   40,370,914      
Beginning balance at Dec. 31, 2025 74,675 $ 5 555,451 11 (480,792)
Beginning balance (in Shares) at Dec. 31, 2025   46,117,164      
Stock-based compensation 1,239   1,239    
Common stock issued under equity award plans (in Shares)   198,163      
Exercise of stock options 91   91    
Exercise of stock options (in Shares)   39,640      
Issuance of common stock, net of cost 6,530   6,530    
Issuance of common stock, net of cost (in Shares)   889,258      
Other comprehensive income (loss) (12)     (12)  
Net income (loss) (12,608)       (12,608)
Ending balance at Mar. 31, 2026 69,915 $ 5 563,311 (1) (493,400)
Ending balance (in Shares) at Mar. 31, 2026   47,244,225      
Beginning balance at Dec. 31, 2025 $ 74,675 $ 5 555,451 11 (480,792)
Beginning balance (in Shares) at Dec. 31, 2025   46,117,164      
Exercise of stock options (in Shares) 85,218        
Other comprehensive income (loss) $ (11)        
Net income (loss) (24,934)        
Ending balance at Jun. 30, 2026 70,843 $ 5 576,564 0 (505,726)
Ending balance (in Shares) at Jun. 30, 2026   49,143,403      
Beginning balance at Mar. 31, 2026 69,915 $ 5 563,311 (1) (493,400)
Beginning balance (in Shares) at Mar. 31, 2026   47,244,225      
Stock-based compensation 2,319   2,319    
Common stock issued under equity award plans (in Shares)   192,839      
Exercise of stock options 72   72    
Exercise of stock options (in Shares)   45,578      
Issuance of common stock under ESPP 85   85    
Issuance of common stock under ESPP (in Shares)   18,683      
Issuance of common stock, net of cost 10,777   10,777    
Issuance of common stock, net of cost (in Shares)   1,642,078      
Other comprehensive income (loss) 1     1  
Net income (loss) (12,326)       (12,326)
Ending balance at Jun. 30, 2026 $ 70,843 $ 5 $ 576,564 $ 0 $ (505,726)
Ending balance (in Shares) at Jun. 30, 2026   49,143,403